| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.6 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |